TWO SIGMA ADVISERS, LP Neurocrine Biosciences, Inc. Transaction History

TWO SIGMA ADVISERS, LP portfolio value:

$63.19M
portfolio value

TWO SIGMA ADVISERS, LP quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +27.99% 130.1K shares 17.87M $106.21 594.97K
Q2 2022 share Decrease -26.07% -163.9K shares -13.63M $97.48 464.87K
Q1 2022 share Increase +225.50% 435.6K shares 42.49M $93.75 628.77K
Q4 2021 share Increase +1044.86% 176.3K shares 14.83M $84.63 193.17K
Q3 2021 share Increase 0.00% 16.87K shares 1.61M $95.91 16.87K
Q4 2020 share Decrease -100.00% -430.29K shares -41.37M $95.85 0
Q3 2020 share Decrease -40.91% -297.87K shares -47.45M $96.16 430.29K
Q2 2020 share Increase +1.32% 9.5K shares 26.63M $122 728.17K
Q1 2020 share Decrease -13.54% -112.5K shares -27.14M $86.55 718.67K
Q4 2019 share Increase +13.40% 98.2K shares 23.29M $107.49 831.17K
Q3 2019 share Decrease -8.30% -66.3K shares -1.43M $90.11 732.97K
Q2 2019 share Increase +5.60% 42.4K shares 802K $84.43 799.27K
Q1 2019 share Increase +21.59% 134.4K shares 22.23M $88.1 756.87K
Q4 2018 share Increase +14.12% 77K shares -22.61M $71.41 622.47K
Q3 2018 share Increase +77.64% 238.4K shares 36.89M $122.95 545.47K
Q2 2018 share Increase +934.86% 277.4K shares 27.70M $98.24 307.07K
Q1 2018 share Increase +167.04% 18.56K shares 1.59M $82.93 29.67K
Q4 2017 share Increase 0.00% 11.11K shares 862K $77.59 11.11K
Q3 2017 share Decrease -100.00% -11.6K shares -534K $61.28 0
Q2 2017 share Decrease -37.30% -6.9K shares -267K $46 11.6K
Q1 2017 share 0.00% 0 shares 85K $43.3 18.5K
Q4 2016 share Increase +157.91% 11.32K shares 353K $38.7 18.5K
Q3 2016 share Increase 0.00% 7.17K shares 363K $50.64 7.17K
Q2 2016 share Decrease -100.00% -39.97K shares -1.58M $45.45 0
Q1 2016 share Increase +35.17% 10.4K shares -92K $39.55 39.97K